Deerfield Management Co

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Deerfield Management Co
CIK #0001009258
Sector Form 13F Holdings Value ($B)
Nuvalent Inc 1.8
UNUM Therapeutics Inc 0.3
Praxis Precision Medicines Inc 0.3
Upjohn Inc 0.3
United Therapeutics Corp 0.3
Revolution Medicines Inc 0.2
Celcuity Inc 0.2
Centene Corp 0.2
Zafgen Inc 0.2
Brookdale Senior Living Inc 0.2
View All
Holdings by Sector ($B)
10.08.06.04.02.00.02011201620212027
EDGAR Form CIK 2011 - 2026
13F-HR [0001009258]
3 [0001009258]
4 [0001009258]
SC 13D [0001009258]
Form 13D/13G Filer Form 13D/13G Subject Filed
Deerfield Management Company LP Series C DA32 Life Science Tech Acquisition Corp [2021-08-10]
Deerfield Management Company LP Series C Deerfield Healthcare Technology Acquisitions Corp [2020-07-30]
Form 3/4/5 Subject 2011 - 2026
Nuvalent Inc
Deerfield Management Company LP
Flynn James E
Deerfield Mgmt HIF LP
Deerfield Mgmt III LP
Parabilis Medicines Inc
Deerfield Private Design Fund III LP
Deerfield Healthcare Innovations Fund LP
Zafgen Inc
Deerfield Private Design Fund IV LP
Deerfield Capital LP
Deerfield Partners LP
Deerfield Mgmt IV LP
ARS Pharmaceuticals Inc
Deerfield Mgmt V LP
BiomX Inc
Deerfield Private Design Fund V LP
Deerfield Healthcare Innovations Fund II LP
Acutus Medical Inc
Bicara Therapeutics Inc
Deerfield Mgmt HIF II LP
AdaptHealth Corp
Fractyl Health Inc
CareMax Inc
DA32 Life Science Tech Acquisition Corp
Oncorus Inc
Frazier Lifesciences Acquisition Corp
Mirum Pharmaceuticals Inc
PepGen Inc
DFP Healthcare Acquisitions Corp
Xilio Therapeutics Inc
Deerfield Special Situations Fund LP
Singular Genomics Systems Inc
Werewolf Therapeutics Inc
Edgewise Therapeutics Inc
Terns Pharmaceuticals Inc
Peak Bio Inc
Lumos Pharma Inc
Graybug Vision Inc
Annexon Inc
Nkarta Inc
Generation Bio Co
Revolution Medicines Inc
Schrodinger Inc
Black Diamond Therapeutics Inc
Q32 Bio Inc
Cabaletta Bio Inc
Korro Bio Inc
Aclaris Therapeutics Inc
Shockwave Medical Inc
Xeris Pharmaceuticals Inc
Arvinas Inc
Aerie Pharmaceuticals Inc
Constellation Pharmaceuticals Inc
Avadel Pharmaceuticals PLC
Deerfield Private Design International II LP
Breaking Stick Holdings LLC
Deerfield Private Design Fund II LP
Proteon Therapeutics Inc
Kiniksa Pharmaceuticals International PLC
Keenova Therapeutics PLC
GYRE Therapeutics Inc
Deerfield International Master Fund LP
Rhythm Pharmaceuticals Inc
Societal CDMO Inc
eHealth Inc
CAS Medical Systems Inc
Invuity Inc
Vanda Pharmaceuticals Inc
Alpine Immune Sciences Inc
Audentes Therapeutics Inc
Axogen Inc
Syros Pharmaceuticals Inc
Xenoport Inc
AveXis Inc
Editas Medicine Inc
Streamline Health Solutions Inc
Alimera Sciences Inc
CytomX Therapeutics Inc
Antares Pharma Inc
RegenxBio Inc
Neos Therapeutics Inc
Deerfield Private Design International LP
Deerfield Private Design Fund L P
Deerfield Private Design International II Ltd
aTYR Pharma Inc
Auspex Pharmaceuticals Inc
SteadyMed Ltd
Invitae Corp
Auxilium Pharmaceuticals Inc
Deerfield Special Situations International Master Fund LP
Dicerna Pharmaceuticals Inc
Loxo Oncology Inc
Adverum Biotechnologies Inc
TriVascular Technologies Inc
Talon Therapeutics Inc
Deerfield Special Situations Fund International LTD
Pernix Sleep Inc
NxStage Medical Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Zafgen Inc LRMR
Common Stock
2026-02-27 Buy 1,084,012 $5.00 5,420,060
Zafgen Inc LRMR
Common Stock
2026-02-27 Buy 831,978 $5.00 4,159,890
Zafgen Inc LRMR
Common Stock
2026-02-27 Buy 2,000,000 $5.00 10,000,000
Zafgen Inc LRMR
Common Stock
2026-02-27 Buy 1,084,010 $5.00 5,420,050
Nuvalent Inc NUVL
Class A Common Stock
2025-11-24 Sell 371,287 $95.45 35,439,344
Nuvalent Inc NUVL
Class A Common Stock
2025-11-24 Sell 371,287 $95.45 35,439,344
Zafgen Inc LRMR
Common Stock
2025-07-31 Buy 3,387,539 $3.20 10,840,125
Zafgen Inc LRMR
Common Stock
2025-07-31 Buy 2,599,932 $3.20 8,319,782
Zafgen Inc LRMR
Common Stock
2025-07-31 Buy 3,387,529 $3.20 10,840,093
ARS Pharmaceuticals Inc SPRY
Class A Common Stock
2025-06-27 Sell 370,074 $18.46 6,831,566
ARS Pharmaceuticals Inc SPRY
Class A Common Stock
2025-06-27 Sell 370,075 $18.46 6,831,584
Nuvalent Inc NUVL
Stock Option (Right to Buy) · derivative
2025-06-18 Grant 4,147 $0.00
Nuvalent Inc NUVL
Class A Common Stock
2025-06-18 Grant 2,647 $0.00
Nuvalent Inc NUVL
Class A Common Stock
2025-06-18 Grant 2,647 $0.00
Nuvalent Inc NUVL
Stock Option (Right to Buy) · derivative
2025-06-18 Grant 4,147 $0.00
Zafgen Inc LRMR
Stock Option (Right to Buy) · derivative
2025-05-13 Grant 19,000 $0.00
BiomX Inc PHGE
Warrants · derivative
2025-04-21 Grant 1,611,864
BiomX Inc PHGE
Warrants · derivative
2025-04-21 Grant 1,611,864
BiomX Inc PHGE
Stock Option (Right to Buy) · derivative
2025-04-14 Grant 17,600 $0.00
BiomX Inc PHGE
Warrants · derivative
2025-02-27 Grant 1,258,614
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com